Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
EOLS on Nasdaq
Shares outstanding
64,879,792
Price per share
$5.02
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
49,024,544
Total reported value
$326,032,646
% of total 13F portfolios
0%
Share change
-6,705,767
Value change
-$41,070,899
Number of holders
167
Price from insider filings
$5.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYNCH TIMOTHY P 9.9% +25% $36,305,352 +$7,299,518 6,425,726 +25% Timothy P. Lynch 31 Dec 2025
Nantahala Capital Management, LLC 8.8% +49% $35,162,902 +$12,129,656 5,726,857 +53% Nantahala Capital Management, LLC 30 Sep 2025
BlackRock, Inc. 6.9% $50,851,038 4,364,896 BlackRock, Inc. 31 Dec 2024
PERCEPTIVE ADVISORS LLC 3.8% -43% $23,461,512 -$15,682,755 2,474,843 -40% Perceptive Advisors LLC 30 Jun 2025
Medytox Inc. 3.4% $24,889,631 2,136,449 Medytox Inc. 31 Dec 2024
TANG CAPITAL MANAGEMENT LLC 1.9% -75% $7,038,160 -$21,197,145 1,245,692 -75% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025

As of 31 Dec 2025, 167 institutional investors reported holding 49,024,544 shares of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS). This represents 76% of the company’s total 64,879,792 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 9% 5,820,649 +1.6% 2.3% $38,707,316
BlackRock, Inc. 6.3% 4,095,300 -8.5% 0% $27,233,746
VANGUARD GROUP INC 5.2% 3,341,804 -2.5% 0% $22,222,997
BRAIDWELL LP 4.8% 3,105,209 0.66% $20,649,640
Frazier Life Sciences Management, L.P. 4.1% 2,630,665 0% 0.47% $17,493,922
MILLENNIUM MANAGEMENT LLC 3.2% 2,093,037 +13% 0.01% $13,918,696
Stonepine Capital Management, LLC 2.5% 1,631,588 +6.2% 8.6% $10,850,060
STATE STREET CORP 2.4% 1,574,851 +3.9% 0% $10,472,759
D. E. Shaw & Co., Inc. 2.4% 1,541,096 +14% 0.01% $10,248,288
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,386,248 -2.2% 0% $9,221,169
CITADEL ADVISORS LLC 2.1% 1,379,131 +134% 0.01% $9,171,221
TANG CAPITAL MANAGEMENT LLC 1.9% 1,245,692 -77% 0.41% $8,283,852
RICE HALL JAMES & ASSOCIATES, LLC 1.8% 1,153,444 -1.3% 0.42% $7,670,403
Soleus Capital Management, L.P. 1.6% 1,070,000 -26% 0.3% $7,115,500
SCHRODER INVESTMENT MANAGEMENT GROUP 1.5% 986,466 -2.8% 0% $6,579,728
ARMISTICE CAPITAL, LLC 1.5% 976,000 0.16% $6,490,400
UBS Group AG 1.4% 881,369 -14% 0% $5,861,104
RENAISSANCE TECHNOLOGIES LLC 1.2% 799,900 +28% 0.01% $5,319,335
PINNACLE ASSOCIATES LTD 1.2% 782,365 +16% 0.07% $5,202,727
Buckley Capital Advisors, LLC 1.1% 744,242 0% 4.3% $4,949,209
MORGAN STANLEY 1.1% 730,664 +175% 0% $4,858,916
EcoR1 Capital, LLC 1% 675,000 0.21% $4,488,750
Soviero Asset Management, LP 1% 655,000 +98% 2.3% $4,355,750
AWH Capital, L.P. 0.96% 625,000 0% 3.8% $4,156,250
BNP PARIBAS FINANCIAL MARKETS 0.87% 564,988 0% 0% $3,757,170

Institutional Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 49,024,544 $326,032,646 -$41,070,899 $6.65 167
2025 Q3 54,269,920 $333,221,285 -$49,039,353 $6.14 158
2025 Q2 58,306,002 $536,933,982 +$27,282,114 $9.21 171
2025 Q1 54,269,937 $652,886,328 +$25,547,799 $12.03 178
2024 Q4 51,921,808 $573,114,520 +$6,665,899 $11.04 164
2024 Q3 50,293,278 $814,501,081 -$14,779,328 $16.20 164
2024 Q2 51,340,763 $557,051,494 +$21,839,886 $10.85 155
2024 Q1 49,347,816 $690,868,493 +$53,544,087 $14.00 160
2023 Q4 45,541,929 $479,552,344 +$47,465,780 $10.53 149
2023 Q3 41,447,331 $378,821,815 +$40,085,326 $9.14 135
2023 Q2 37,278,540 $271,085,912 +$16,634,153 $7.27 132
2023 Q1 34,126,762 $288,714,148 +$41,941,872 $8.46 124
2022 Q4 29,273,655 $219,845,469 +$14,363,180 $7.51 116
2022 Q3 25,565,680 $205,795,765 -$5,087,386 $8.05 122
2022 Q2 25,348,901 $294,043,424 +$27,306,633 $11.60 117
2022 Q1 23,065,245 $258,202,339 +$27,115,832 $11.22 115
2021 Q4 20,576,998 $133,137,102 +$16,160,367 $6.51 102
2021 Q3 17,623,312 $134,773,188 +$2,126,205 $7.62 109
2021 Q2 16,226,875 $205,283,641 +$96,350,898 $12.65 111
2021 Q1 8,608,655 $111,825,892 +$19,807,970 $12.99 92
2020 Q4 7,776,423 $26,127,429 +$1,508,358 $3.36 79
2020 Q3 7,265,841 $28,771,905 -$11,631,486 $3.91 77
2020 Q2 9,284,051 $49,207,493 -$20,294,810 $5.30 80
2020 Q1 14,269,284 $58,934,912 -$12,174,946 $4.15 95
2019 Q4 13,995,058 $170,310,558 +$99,390,874 $12.17 101
2019 Q3 5,663,928 $88,460,159 +$6,453,980 $15.62 92
2019 Q2 5,294,303 $77,402,817 +$17,407,129 $14.62 103
2019 Q1 3,901,128 $88,035,182 -$2,688,589 $22.57 90
2018 Q4 5,405,565 $64,325,153 -$25,490,499 $11.90 72
2018 Q3 6,656,409 $123,935,961 +$57,861,875 $18.62 68
2018 Q2 3,521,598 $98,567,769 +$802,066 $27.99 54
2018 Q1 4,445,338 $40,139,664 +$40,139,664 $9.03 39
2016 Q2 0 $0 -$286,000 $5.02 0
2016 Q1 12,761 $286,000 $22.41 1